Company / Cash & Equivalents
MILESTONE SCIENTIFIC INC. Cash & Equivalents History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$2.6M
FY2017
5-year range
$165.2K / $10.4M
FY2013-FY2017
Trend
-26.8%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $10M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2017 with a 5-year CAGR of +74.0%.
Declined from $10M to $3M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +32.0%
- 5-Year CAGR
- +74.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +74.0%, indicating consistent growth.
- In FY2017, cash & equivalents decreased 26.8% year-over-year.
- Peak cash & equivalents was recorded in FY2015.
- Lowest cash & equivalents in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -3.97 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $2.6M | -26.8% |
| FY2016 | $3.6M | -65.3% |
| FY2015 | $10.4M | +803.8% |
| FY2014 | $1.1M | +594.2% |
| FY2013 | $165.2K | +0.0% |
| FY2012 | $165.2K | -73.6% |
| FY2011 | $627.1K | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026